Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J. Creighton, Jenny C. Chang, Melissa D. Landis et al.|Proceedings of the National Academy of Sciences|2009Cited by 1.4k
Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to TrastuzumabDana Faratian, David J. Harrison|Cancer Research|2009Cited by 160